Buy, Sell, Or Hold Johnson & Johnson Stock At $140? [Forbes]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Forbes
A picture taken on November 30, 2017 shows the logo of US multinational medical devices and... [+]pharmaceutical company Johnson & Johnson at the entrance of the research and development plant, in Val-de-Reuil, northwestern France. / AFP PHOTO / CHARLY TRIBALLEAU (Photo credit should read CHARLY TRIBALLEAU/AFP via Getty Images)(NYSE: JNJ)What Factors Drove 9.1% Change In Johnson & Johnson Stock Between 2017 And Now?The stock price didn’t gain over the past two years despite steady revenue growth for the company. Johnson & Johnson’s revenues were up 7.3% from 2017 to 2019. This combined with a 9x jump in net income margin from (a depressed) 1.7% in 2017 to 18.4% in 2019, and a reduction in share count due to stock repurchases worth $19 billion, helped earnings per share swell 1092% (from low levels). Note that these numbers are based on Johnson & Johnson’s GAAP numbers. The reason for the low margin in 2017 was tax provisions of $16.3 billion, as compared to $3.3 billion in the prior y
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Dividend Aristocrats in a Shaky Market: KO, PG, JNJ, and 2 Others Built to Last [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson (JNJ) had its price target raised by JPMorgan Chase & Co. from $225.00 to $250.00. They now have a "neutral" rating on the stock.MarketBeat
- Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second LinePR Newswire
JNJ
Earnings
- 1/21/26 - Beat
JNJ
Sec Filings
- 3/3/26 - Form 4
- 2/27/26 - Form 144
- 2/23/26 - Form 4
- JNJ's page on the SEC website